Although our study observed close association of serum BMP9 with the severity of MetS and NAFLD, there are some limitations including the small sample size, and the cross-sectional study design did not allow us to establish causality between serum BMP9 and NAFLD development. The gene discussed is GDF2; the disease is metabolic syndrome.